These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 21907637)
1. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients. Vanderhelst E; De Meirleir L; Verbanck S; Piérard D; Vincken W; Malfroot A J Cyst Fibros; 2012 Jan; 11(1):2-7. PubMed ID: 21907637 [TBL] [Abstract][Full Text] [Related]
2. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Dasenbrook EC; Merlo CA; Diener-West M; Lechtzin N; Boyle MP Am J Respir Crit Care Med; 2008 Oct; 178(8):814-21. PubMed ID: 18669817 [TBL] [Abstract][Full Text] [Related]
3. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE; Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151 [TBL] [Abstract][Full Text] [Related]
4. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Sawicki GS; Rasouliyan L; Pasta DJ; Regelmann WE; Wagener JS; Waltz DA; Ren CL Pediatr Pulmonol; 2008 Nov; 43(11):1117-1123. PubMed ID: 18846559 [TBL] [Abstract][Full Text] [Related]
5. The impact of MRSA infection in the airways of children with cystic fibrosis; a case-control study. Cox DW; Kelly C; Rush R; O'Sullivan N; Canny G; Linnane B Ir Med J; 2011; 104(10):305-8. PubMed ID: 22256443 [TBL] [Abstract][Full Text] [Related]
6. Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients. Vanderhelst E; De Wachter E; Willekens J; Piérard D; Vincken W; Malfroot A J Cyst Fibros; 2013 Dec; 12(6):662-6. PubMed ID: 23706641 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis. Nadesalingam K; Conway SP; Denton M J Cyst Fibros; 2005 Mar; 4(1):49-52. PubMed ID: 15752681 [TBL] [Abstract][Full Text] [Related]
8. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis. Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443 [TBL] [Abstract][Full Text] [Related]
9. A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF. Dalbøge CS; Pressler T; Høiby N; Nielsen KG; Johansen HK J Cyst Fibros; 2013 Jan; 12(1):42-8. PubMed ID: 22784398 [TBL] [Abstract][Full Text] [Related]
10. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469 [TBL] [Abstract][Full Text] [Related]